Cocrystal Pharma, Inc.
-
Ticker
COCP
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Tucker, Georgia
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, SARS-CoV-2 virus, hepatitis C viruses, and norovirus infections. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs.
Cocrystal Pharma, Inc.
Most Recent Annual Report
MOST RECENT
2021 Annual Report and Form 10K
Older/Archived Annual Reports